Our October issue review highlights include:
· Translational CNS medicines research
· Computational methods for drug resistance and design
· Subtleties in GPCR drug discovery
· Tumor-initiating cells
The leading story of this issue of Drug Discovery Today, by Alan M. Palmerand Mohammad S. Alavijeh considers the factors that are important in translating neuroscience research into CNS medicines. The authors discuss complexity of the human brain, the liability of CNS drugs to cause CNS side effects and the requirement of CNS medicines to cross the blood–CNS barrier.
Click here to view the Drug Discovery Today October issue on ScienceDirect
To register for the Drug Discovery Today Digital Edition click here.